MedPath

Pfizer Italia S.R.L.

🇨🇷Costa Rica
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

NMPA:10
PHILIPPINES:9
CIMA_AEMPS:1

Drug Approvals

Medroxyprogesterone Acetate Tablets

Product Name
法禄达
Approval Number
国药准字HJ20140648
Approval Date
Jun 14, 2023
NMPA

Estramustine Phosphate Capsules

Product Name
艾去适
Approval Number
国药准字HJ20170266
Approval Date
Mar 21, 2022
NMPA

Cytarabine for Injection

Product Name
赛德萨
Approval Number
国药准字HJ20160402
Approval Date
Jun 8, 2021
NMPA

Cytarabine for Injection

Product Name
赛德萨
Approval Number
国药准字HJ20160403
Approval Date
Jun 8, 2021
NMPA

Exemestane Tablets

Product Name
阿诺新
Approval Number
国药准字HJ20160054
Approval Date
Sep 4, 2020
NMPA

Exemestane Tablets

Product Name
阿诺新
Approval Number
国药准字HJ20160053
Approval Date
Sep 4, 2020
NMPA

Exemestane Tablets

Product Name
阿诺新
Approval Number
国药准字HJ20160052
Approval Date
Sep 4, 2020
NMPA

Tolterodine Tartrate Tablets

Product Name
酒石酸托特罗定片
Approval Number
H20140419
Approval Date
Jun 4, 2014
NMPA

Tolterodine Tartrate Tablets

Product Name
酒石酸托特罗定片
Approval Number
H20140418
Approval Date
Jun 4, 2014
NMPA

Daunorubicin Hydrochloride for Injection

Product Name
注射用盐酸柔红霉素
Approval Number
H20130940
Approval Date
Dec 19, 2013
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.